• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TAL1 在 T 细胞急性淋巴细胞白血病中的调控机制及与背景相关的作用。

Regulatory mechanisms and context-dependent roles of TAL1 in T-cell acute lymphoblastic leukemia.

机构信息

Cancer Science Institute of Singapore, National University of Singapore, 117599.

Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 117599; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya.

出版信息

Haematologica. 2024 May 1;109(5):1359-1372. doi: 10.3324/haematol.2023.283450.

DOI:10.3324/haematol.2023.283450
PMID:37855064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11063860/
Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy derived from thymic T-cell precursors. Approximately 40-60% of T-ALL cases exhibit aberrant overexpression of the TAL1 oncogenic transcription factor. Here, we provide a comprehensive view of the TAL1-induced transcriptional program in human T-ALL cells using a rapid protein degradation system coupled with integrative approaches. Our study demonstrates that TAL1 targets can be classified into several groups, each of which exhibits unique gene expression kinetics, chromatin features, and regulatory mechanisms. Group A genes are highly dependent on TAL1, many of which are not expressed in normal T cells or TAL1-negative T-ALL cells, representing an oncogenic TAL1 signature. The TAL1 complex predominantly activates group A genes. TAL1's effect is not replaceable with its regulatory partners GATA3 or RUNX1. In contrast, group B genes, many of which are generally expressed across different T-ALL subgroups, exhibit densely-connected chromatin-chromatin interactions and demonstrate the collaborative roles played by TAL1 with other transcription factors. Interestingly, TAL1 cooperates with NOTCH1 to regulate gene expression in TAL1-positive T-ALL cells, whereas it potentially antagonizes the NOTCH1-MYC pathway and leads to lethality in TAL1-negative/ TLX3-positive cells, demonstrating the context-dependent roles of TAL1.

摘要

T 细胞急性淋巴细胞白血病(T-ALL)是一种源自胸腺 T 细胞前体的侵袭性恶性肿瘤。大约 40-60%的 T-ALL 病例表现出 TAL1 致癌转录因子的异常过表达。在这里,我们使用快速蛋白降解系统结合综合方法,提供了 TAL1 在人类 T-ALL 细胞中诱导的转录程序的全面视图。我们的研究表明,TAL1 靶标可以分为几类,每类都具有独特的基因表达动力学、染色质特征和调控机制。A 组基因高度依赖于 TAL1,其中许多基因在正常 T 细胞或 TAL1 阴性 T-ALL 细胞中不表达,代表了致癌的 TAL1 特征。TAL1 复合物主要激活 A 组基因。TAL1 的作用不能被其调节伙伴 GATA3 或 RUNX1 取代。相比之下,B 组基因,其中许多在不同的 T-ALL 亚组中普遍表达,表现出密集连接的染色质-染色质相互作用,并展示了 TAL1 与其他转录因子协同作用的作用。有趣的是,TAL1 与 NOTCH1 合作调节 TAL1 阳性 T-ALL 细胞中的基因表达,而在 TAL1 阴性/TLX3 阳性细胞中,它可能拮抗 NOTCH1-MYC 途径并导致细胞死亡,这表明 TAL1 的作用具有上下文依赖性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/492e381b2628/1091359.fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/d820ca9b7c80/1091359.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/c065a7568c66/1091359.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/21f34fc350dc/1091359.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/be371a2200d1/1091359.fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/62a845208319/1091359.fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/492e381b2628/1091359.fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/d820ca9b7c80/1091359.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/c065a7568c66/1091359.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/21f34fc350dc/1091359.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/be371a2200d1/1091359.fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/62a845208319/1091359.fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033d/11063860/492e381b2628/1091359.fig6.jpg

相似文献

1
Regulatory mechanisms and context-dependent roles of TAL1 in T-cell acute lymphoblastic leukemia.TAL1 在 T 细胞急性淋巴细胞白血病中的调控机制及与背景相关的作用。
Haematologica. 2024 May 1;109(5):1359-1372. doi: 10.3324/haematol.2023.283450.
2
The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.TAL1 复合物通过激活人 T 细胞急性淋巴细胞白血病中的 miR-223 靶向 FBXW7 肿瘤抑制因子。
J Exp Med. 2013 Jul 29;210(8):1545-57. doi: 10.1084/jem.20122516. Epub 2013 Jul 15.
3
Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia.鉴定 TAL1 复合物调控的 T 细胞急性淋巴细胞白血病中的新型长链非编码 RNA。
Leukemia. 2018 Oct;32(10):2138-2151. doi: 10.1038/s41375-018-0110-4. Epub 2018 Mar 26.
4
Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.异常的TAL1激活是由人类T细胞急性淋巴细胞白血病中的染色体间相互作用介导的。
Leukemia. 2014 Feb;28(2):349-61. doi: 10.1038/leu.2013.158. Epub 2013 May 23.
5
Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.人类 T 细胞急性淋巴细胞白血病中由 TAL1 复合物控制的核心转录调控回路。
Cancer Cell. 2012 Aug 14;22(2):209-21. doi: 10.1016/j.ccr.2012.06.007.
6
MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia.miR-7 通过靶向 T 细胞急性淋巴细胞白血病中的癌基因 TAL1 发挥肿瘤抑制作用。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820934130. doi: 10.1177/1533033820934130.
7
NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.NKX3.1 是 TAL1 的一个直接靶标基因,介导 TAL1 表达的人类 T 细胞急性淋巴细胞白血病的增殖。
J Exp Med. 2010 Sep 27;207(10):2141-56. doi: 10.1084/jem.20100745. Epub 2010 Sep 20.
8
ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.ARID5B作为TAL1复合体的关键下游靶点,可激活致癌转录程序并促进T细胞白血病发生。
Genes Dev. 2017 Dec 1;31(23-24):2343-2360. doi: 10.1101/gad.302646.117. Epub 2018 Jan 11.
9
TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.TAL1 劫持 MYCN 增强子,诱导 T 细胞急性淋巴细胞白血病中的 MYCN 表达和对甲羟戊酸途径的依赖。
Leukemia. 2023 Oct;37(10):1969-1981. doi: 10.1038/s41375-023-01993-y. Epub 2023 Aug 17.
10
The enhancer RNA activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia.增强子 RNA 激活 T 细胞急性淋巴细胞白血病中的致癌转录程序。
Blood. 2019 Jul 18;134(3):239-251. doi: 10.1182/blood.2018874503. Epub 2019 May 10.

引用本文的文献

1
Identification of rare and pathogenic TAL2 gene mutations in B-lineage acute lymphoblastic leukemia (B-ALL) using mutational screening and comprehensive bioinformatics analysis.利用突变筛查和综合生物信息学分析鉴定B系急性淋巴细胞白血病(B-ALL)中罕见的致病性TAL2基因突变。
Mol Biol Rep. 2025 Jan 16;52(1):125. doi: 10.1007/s11033-025-10229-4.
2
ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia.完全降解——T细胞急性淋巴细胞白血病中TAL1的快速dTAG蛋白酶解
Haematologica. 2024 May 1;109(5):1325-1327. doi: 10.3324/haematol.2023.284447.

本文引用的文献

1
How transcription factors drive choice of the T cell fate.转录因子如何驱动 T 细胞命运的选择。
Nat Rev Immunol. 2021 Mar;21(3):162-176. doi: 10.1038/s41577-020-00426-6. Epub 2020 Sep 11.
2
Oncorequisite role of an aldehyde dehydrogenase in the pathogenesis of T-cell acute lymphoblastic leukemia.醛脱氢酶在 T 细胞急性淋巴细胞白血病发病机制中的必要作用。
Haematologica. 2021 Jun 1;106(6):1545-1558. doi: 10.3324/haematol.2019.245639.
3
GATA3-Controlled Nucleosome Eviction Drives Enhancer Activity in T-cell Development and Leukemia.
GATA3 调控的核小体驱逐驱动 T 细胞发育和白血病中的增强子活性。
Cancer Discov. 2019 Dec;9(12):1774-1791. doi: 10.1158/2159-8290.CD-19-0471. Epub 2019 Sep 13.
4
4C-seq from beginning to end: A detailed protocol for sample preparation and data analysis.4C-seq 从始至终:样本制备和数据分析的详细方案。
Methods. 2020 Jan 1;170:17-32. doi: 10.1016/j.ymeth.2019.07.014. Epub 2019 Jul 26.
5
The dTAG system for immediate and target-specific protein degradation.dTAG 系统用于即时和靶向特异性蛋白质降解。
Nat Chem Biol. 2018 May;14(5):431-441. doi: 10.1038/s41589-018-0021-8. Epub 2018 Mar 26.
6
ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.ARID5B作为TAL1复合体的关键下游靶点,可激活致癌转录程序并促进T细胞白血病发生。
Genes Dev. 2017 Dec 1;31(23-24):2343-2360. doi: 10.1101/gad.302646.117. Epub 2018 Jan 11.
7
Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.增强子分析可识别关键癌症基因并表征成人T细胞白血病中的细胞特性。
Blood. 2017 Nov 23;130(21):2326-2338. doi: 10.1182/blood-2017-06-792184. Epub 2017 Oct 4.
8
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.儿童及青年T细胞系急性淋巴细胞白血病的基因组图谱
Nat Genet. 2017 Aug;49(8):1211-1218. doi: 10.1038/ng.3909. Epub 2017 Jul 3.
9
Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.在T细胞急性淋巴细胞白血病中,致癌转录因子异常激活GIMAP增强子。
Leukemia. 2017 Aug;31(8):1798-1807. doi: 10.1038/leu.2016.392. Epub 2016 Dec 28.
10
Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution.谱系特异性和单细胞染色质可及性图谱描绘了人类造血作用和白血病的演变。
Nat Genet. 2016 Oct;48(10):1193-203. doi: 10.1038/ng.3646. Epub 2016 Aug 15.